• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-490-3p 通过调控组蛋白去乙酰化酶 2 来调节前列腺癌的进展。

miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.

机构信息

Urology Department, Peking Union Medical College Hospital, No. 1 ShuaiFuYuan, DongCheng District, Beijing, P. R. China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):539-546. doi: 10.26355/eurrev_201901_16866.

DOI:10.26355/eurrev_201901_16866
PMID:30720161
Abstract

OBJECTIVE

microRNAs (miRNAs) were regarded as critical participators for human cancers progression including prostate cancer (PCa) and have the potential to be used as treatment targets for cancers. Herein, we validated a tumor-suppressive miRNA, miR-490-3p, which may suppress PCa progression. Histone deacetylase 2 (HDAC2) is a protein that aberrantly expressed in several cancers. However, the role of HDAC2 in the progression of PCa has not been fully elucidated.

MATERIALS AND METHODS

Expression of miR-490-3p and HDAC2 in PCa was investigated. The effects of miR-490-3p or HDAC2 expression on PCa cell behaviors were analyzed. Association between miR-490-3p and HDAC2 was analyzed by luciferase activity reporter assay and Western blot assay.

RESULTS

We demonstrated that miR-490-3p functioned as a tumor-suppressive role in PCa progression. We found miR-490-3p expression was decreased in PCa cell lines. Down-regulation of miR-490-3p promoted the growth, migration, invasion but inhibited apoptosis of PCa cells. HDAC2 was validated as a direct target of miR-490-3p and promoted the progression of PCa cells. Further studies showed that HDAC2 could reverse the effects of miR-490-3p on growth, migration, invasion and apoptosis of PCa cells.

CONCLUSIONS

Our data highlighted the key role of miR-490-3p in the progression of PCa. Thus, miR-490-3p may be a novel cancer-specific therapeutic.

摘要

目的

微小 RNA(miRNA)被认为是人类癌症进展的关键参与者,包括前列腺癌(PCa),并有可能成为癌症治疗的靶点。在此,我们验证了一种肿瘤抑制 miRNA,miR-490-3p,它可能抑制 PCa 的进展。组蛋白去乙酰化酶 2(HDAC2)是一种在多种癌症中异常表达的蛋白质。然而,HDAC2 在 PCa 进展中的作用尚未完全阐明。

材料和方法

研究了 miR-490-3p 和 HDAC2 在 PCa 中的表达。分析了 miR-490-3p 或 HDAC2 表达对 PCa 细胞行为的影响。通过荧光素酶活性报告基因检测和 Western blot 检测分析 miR-490-3p 和 HDAC2 之间的关联。

结果

我们证明 miR-490-3p 在 PCa 进展中发挥肿瘤抑制作用。我们发现 miR-490-3p 在 PCa 细胞系中的表达降低。下调 miR-490-3p 促进了 PCa 细胞的生长、迁移、侵袭,但抑制了其凋亡。HDAC2 被验证为 miR-490-3p 的直接靶标,并促进了 PCa 细胞的进展。进一步的研究表明,HDAC2 可以逆转 miR-490-3p 对 PCa 细胞生长、迁移、侵袭和凋亡的影响。

结论

我们的数据强调了 miR-490-3p 在 PCa 进展中的关键作用。因此,miR-490-3p 可能是一种新的癌症特异性治疗方法。

相似文献

1
miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.miR-490-3p 通过调控组蛋白去乙酰化酶 2 来调节前列腺癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):539-546. doi: 10.26355/eurrev_201901_16866.
2
MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.MiR-506-3p通过靶向GALNT4在前列腺癌中作为一种新型肿瘤抑制因子发挥作用。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5133-5138. doi: 10.26355/eurrev_201906_18177.
3
Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.长链非编码 RNA TUG1 通过调控 miR-128-3p/YES1 轴促进前列腺癌进展。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):619-632. doi: 10.26355/eurrev_202001_20038.
4
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation.微小RNA-92a-3p通过在软骨形成和降解过程中直接靶向组蛋白去乙酰化酶2来调节软骨特异性基因的表达。
Osteoarthritis Cartilage. 2017 Apr;25(4):521-532. doi: 10.1016/j.joca.2016.11.006. Epub 2016 Nov 21.
5
MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma.MicroRNA-455-3p 通过靶向 HDAC2 调节肝癌细胞周期发挥肿瘤抑制作用。
Environ Toxicol. 2022 Jul;37(7):1675-1685. doi: 10.1002/tox.23516. Epub 2022 Mar 14.
6
The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics.miR-455-3p/HDAC2 轴在肝纤维化的进展和逆转中起着关键作用,并且受表观遗传学调控。
FASEB J. 2021 Jul;35(7):e21700. doi: 10.1096/fj.202002319RRR.
7
lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.lncRNA-SNHG15 通过靶向 miR-490-3p/组蛋白去乙酰化酶 2 轴促进肝癌的发展。
World J Gastroenterol. 2019 Oct 14;25(38):5789-5799. doi: 10.3748/wjg.v25.i38.5789.
8
MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3.miR-363-3p 通过靶向 Dickkopf 3 促进前列腺癌肿瘤进展。
J Clin Lab Anal. 2022 Apr;36(4):e24360. doi: 10.1002/jcla.24360. Epub 2022 Mar 18.
9
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.拟肿瘤抑制因子 miR-1-3p 通过抑制 E2F5 和 PFTK1 来调节前列腺癌细胞的侵袭性。
J Exp Clin Cancer Res. 2018 Sep 5;37(1):219. doi: 10.1186/s13046-018-0895-z.
10
TGF-β1-regulated miR-3691-3p targets and to inhibit prostate cancer progression.TGF-β1 调节的 miR-3691-3p 靶向和抑制前列腺癌进展。
Asian J Androl. 2021 Mar-Apr;23(2):188-196. doi: 10.4103/aja.aja_60_20.

引用本文的文献

1
HDAC2 as a target for developing anti-cancer drugs.组蛋白去乙酰化酶2作为开发抗癌药物的靶点。
Comput Struct Biotechnol J. 2023 Mar 13;21:2048-2057. doi: 10.1016/j.csbj.2023.03.016. eCollection 2023.
2
The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer.沉默调节蛋白在乳腺癌和前列腺癌中的作用机制
Cancers (Basel). 2022 Oct 19;14(20):5118. doi: 10.3390/cancers14205118.
3
LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA.LINC00958 通过靶向 miR-490-3p 和 AURKA 促进膀胱癌发生。
BMC Cancer. 2021 Oct 26;21(1):1145. doi: 10.1186/s12885-021-08882-6.
4
Role of miR-490-3p in blocking bladder cancer growth through targeting the RNA-binding protein PCBP2.miR-490-3p 通过靶向 RNA 结合蛋白 PCBP2 抑制膀胱癌生长的作用。
Kaohsiung J Med Sci. 2022 Jan;38(1):30-37. doi: 10.1002/kjm2.12457. Epub 2021 Oct 7.
5
MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?致癌过程中的微小RNA-490-3p和-490-5p:殊途同归还是目标各异?
Oncol Lett. 2021 Sep;22(3):678. doi: 10.3892/ol.2021.12939. Epub 2021 Jul 22.
6
Long non-coding RNA CCAT1 sponges miR-490 to enhance cell proliferation and migration of non-small cell lung cancer.长链非编码 RNA CCAT1 通过海绵吸附 miR-490 促进非小细胞肺癌细胞增殖和迁移。
Thorac Cancer. 2021 Feb;12(3):364-371. doi: 10.1111/1759-7714.13758. Epub 2020 Dec 15.
7
Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.外生骨疣蛋白 1 作为一种新型的鳞状细胞肺癌预后和预测生物标志物:基于生物信息学分析的研究。
Cancer Med. 2021 Apr;10(8):2787-2801. doi: 10.1002/cam4.3643. Epub 2020 Dec 13.
8
MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma.微小RNA-490-3p抑制肺腺癌的恶性进展。
Cancer Manag Res. 2020 Oct 30;12:10975-10984. doi: 10.2147/CMAR.S258182. eCollection 2020.
9
Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.幽门螺杆菌沉默 miR490-3p 可激活 DARPP-32,导致吉非替尼耐药。
Cancer Lett. 2020 Oct 28;491:87-96. doi: 10.1016/j.canlet.2020.07.014. Epub 2020 Jul 29.
10
LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p.长链非编码 RNA LINC00483 通过海绵吸附 miR-490-3p 调控 MAPK1 表达促进胃癌发展。
Biol Res. 2020 Apr 15;53(1):14. doi: 10.1186/s40659-020-00283-6.